Molecular dynamics studies on both bound and unbound renin protease

References

• Ahmad, E., Rabbani, G., Zaidi, N., Khan, M. A., Qadeer, A., Ishtikhar, M., … Khan, R. H. (2012). Revisiting ligand-induced conformational changes in proteins: essence, advancements, implications and future challenges. Journal of Biomolecular Structure & Dynamics. doi:10.1080/07391102.2012.706081.
   Google Scholar
• Andreeva, N. S., & Rumsh, L. D. (2001). Analysis of crystal structures of aspartic proteinases: On the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes. Protein Science, 10, 2439–2450.
   PubMedGoogle Scholar
• Barman, A., Schurer, S., & Prabhakar, R. (2011). Computational modeling of substrate specificity and catalysis of the beta-secretase (BACE1) enzyme. Biochemistry, 50, 4337–4349.
   PubMedGoogle Scholar
• Bayly, C. I., Cieplak, P., Cornell, W. D., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges – the resp model. Journal of Physical Chemistry, 97, 10269–10280.
   Web of Science ®Google Scholar
• Bezencon, O., Bur, D., Weller, T., Richard-Bildstein, S., Remen, L., Sifferlen, T., … Fischli, W. (2009). Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors. Journal of Medicinal Chemistry, 52, 3689–3702.
   PubMed Web of Science ®Google Scholar
• Blundell, T., Sibanda, B. L., & Pearl, L. (1983). 3-Dimensional structure, specificity and catalytic mechanism of renin. Nature, 304, 273–275.
   PubMed Web of Science ®Google Scholar
• Bras, N. F., Fernandes, P. A., & Ramos, M. J. (2012). The catalytic mechanism of mouse renin studied with QM/MM calculations. Physical Chemistry Chemical Physics, 14, 12605–12613.
   PubMed Web of Science ®Google Scholar
• Cascella, M., Micheletti, C., Rothlisberger, U., & Carloni, P. (2005). Evolutionarily conserved functional mechanics across pepsin-like and retroviral aspartic proteases. Journal of the American Chemical Society, 127, 3734–3742.
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., … Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26, 1668–1688.
   PubMed Web of Science ®Google Scholar
• Case, D. A., Darden, T. A., Cheatham, T. E., III, Simmerling, C. L., Wang, J., Duke, R. E., … Kollman, P. A. (2008). AMBER 10. San Francisco: University of California.
   Google Scholar
• Coates, L., Tuan, H. F., Tomanicek, S., Kovalevsky, A., Mustyakimov, M., Erskine, P. & Cooper, J. (2008). The catalytic mechanism of an aspartic proteinase explored with neutron and X-ray diffraction. Journal of the American Chemical Society, 130, 7235.
   Google Scholar
• Cooper, J. B. (2002). Aspartic proteinases in disease: A structural perspective. Current Drug Targets, 3, 155–173.
   PubMed Web of Science ®Google Scholar
• Davies, D. R. (1990). The structure and function of the aspartic proteinases. Annual Review of Biophysics and Biophysical Chemistry, 19, 189–215.
   PubMedGoogle Scholar
• DeLeon, K. Y., Patel, A. P., Kuczera, K., Johnson, C. K., & Jas, G. S. (2012). Structure and reorintational dynamics of angiotensin I and II: A microscopic physical insight. Journal of Biomolecular Structure & Dynamics, 29, 671–690.
   PubMedGoogle Scholar
• Dhanaraj, V., Dealwis, C. G., Frazao, C., Badasso, M., Sibanda, B. L., Tickle, I. J., … Hoover, D. J. (1992). X-ray analyses of peptide-inhibitor complexes define the structural basis of specificity for human and mouse renins. Nature, 357, 466–472.
   PubMed Web of Science ®Google Scholar
• Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G. M., Zhang, W., … Kollman, P. (2003). A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 24, 1999–2012.
   PubMed Web of Science ®Google Scholar
• Eder, J., Hommel, U., Cumin, F., Martoglio, B., & Gerhartz, B. (2007). Aspartic proteases in drug discovery. Current Pharmaceutical Design, 13, 271–285.
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. Journal of Chemical Physics, 103, 8577–8593.
   Web of Science ®Google Scholar
• Fernandez, A., Tawfik, D. S., Berkhout, B., Sanders, R. W., Kloczkowski, A., Sen, T. Z., & Jernigan, R. L. (2005). Protein promiscuity: Drug resistance and native functions – HIV-1 case. Journal of Biomolecular Structure & Dynamics, 22, 615–624.
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., … Fox, D. J. (2009). Gaussian 09. Wallingford, CT: Gaussian, Inc.
   Google Scholar
• Gorfe, A. A., & Caflisch, A. (2005). Functional plasticity in the substrate binding site of beta-secretase. Structure, 13, 1487–1498.
   PubMed Web of Science ®Google Scholar
• Hong, L., & Tang, J. (2004). Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis. Biochemistry, 43, 4689–4695.
   PubMed Web of Science ®Google Scholar
• Hornak, V., Okur, A., Rizzo, R. C., & Simmerling, C. (2006a). HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state. Journal of the American Chemical Society, 128, 2812–2813.
   PubMed Web of Science ®Google Scholar
• Hornak, V., Okur, A., Rizzo, R. C., & Simmerling, C. (2006b). HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations. Proceedings of the National Academy of Sciences of the United States of America, 103, 915–920.
   PubMed Web of Science ®Google Scholar
• Izaguirre, J. A., Catarello, D. P., Wozniak, J. M., & Skeel, R. D. (2001). Langevin stabilization of molecular dynamics. Journal of Chemical Physics, 114, 2090–2098.
   Web of Science ®Google Scholar
• Jensen, C., Herold, P., & Brunner, H. R. (2008). Aliskiren: The first renin inhibitor for clinical treatment. Nature Reviews Drug Discovery, 7, 399–410.
   PubMed Web of Science ®Google Scholar
• Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., … Hobart, P. M. (1989). X-ray-analysis of hiv-1 proteinase at 2.7 a resolution confirms structural homology among retroviral enzymes. Nature, 342, 299–302.
   PubMed Web of Science ®Google Scholar
• Northrop, D. B. (2001). Follow the protons: A low-barrier hydrogen bond unifies the mechanisms of the aspartic proteases. Accounts of Chemical Research, 34, 790–797.
   PubMed Web of Science ®Google Scholar
• Paschalidou, K., Neumann, U., Gerhartz, B., & Tzougraki, C. (2004). Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions. Biochemical Journal, 382, 1031–1038.
   PubMedGoogle Scholar
• Patel, S., Vuillard, L., Cleasby, A., Murray, C. W., & Yon, J. (2004). Apo and inhibitor complex structures of BACE (beta-secretase). Journal of Molecular Biology, 343, 407–416.
   PubMed Web of Science ®Google Scholar
• Pietrucci, F., Marinelli, F., Carloni, P., & Laio, A. (2009). Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations. Journal of the American Chemical Society, 131, 11811–11818.
   PubMed Web of Science ®Google Scholar
• Politi, A., Durdagi, S., Moutevelis-Minakakis, P., Kokotos, G., Papadopoulos, M. G., & Mavromoustakos, T. (2009). Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases. European Journal of Medicinal Chemistry, 44, 3703–3711.
   PubMed Web of Science ®Google Scholar
• Politi, A., Leonis, G., Tzoupis, H., Ntountaniotis, D., Papadopoulos, M. G., Grdadolnik, S. G., & Mavromoustakos, T. (2011). Conformational properties and energetic analysis of aliskiren in solution and receptor site. Molecular Informatics, 30, 973–985.
   PubMed Web of Science ®Google Scholar
• Rahuel, J., Rasetti, V., Maibaum, J., Rueger, H., Goschke, R., Cohen, N. C., … Grutter, M. G. (2000). Structure-based drug design: The discovery of novel nonpeptide orally active inhibitors of human renin. Chemistry & Biology, 7, 493–504.
   PubMed Web of Science ®Google Scholar
• Remen, L., Bezencon, O., Richard-Bildstein, S., Prade, D. B. L., Corminboeuf, O., Boss, C., … Fischli, W. (2009). New classes of potent and bioavailable human renin inhibitors. Bioorganic & Medicinal Chemistry Letters, 19, 6762–6765.
   PubMed Web of Science ®Google Scholar
• Ryckaert, J. P., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical-integration of Cartesian equations of motion of a system with constraints – molecular-dynamics of N-alkanes. Journal of Computational Physics, 23, 327–341.
   Web of Science ®Google Scholar
• Sadiq, S. K., & De Fabritiis, G. (2010). Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing. Proteins-Structure Function and Bioinformatics, 78, 2873–2885.
   PubMed Web of Science ®Google Scholar
• Shang, Y., & Simmerling, C. (2012). Molecular dynamics applied in drug discovery: The case of HIV-1 protease. Computational Drug Discovery and Design, 819, 527–549 . [R. Baron].
   Google Scholar
• Shao, J. Y., Tanner, S. W., Thompson, N., & Cheatham, T. E. (2007). Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms. Journal of Chemical Theory and Computation, 3, 2312–2334.
   PubMed Web of Science ®Google Scholar
• Sielecki, A. R., Hayakawa, K., Fujinaga, M., Murphy, M. E. P., Fraser, M., Muir, A. K., … James, M. N. G. (1989). Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. Science, 243, 1346–1351.
   PubMed Web of Science ®Google Scholar
• Sinha, N., Tsai, C. J., & Nussinov, R. (2001). Building blocks, hinge-bending motions and protein topology. Journal of Biomolecular Structure & Dynamics, 19, 369–380.
   PubMed Web of Science ®Google Scholar
• Steiner, D., Oostenbrink, C., Diederich, F., Zurcher, M., & van Gunsteren, W. F. (2011). Calculation of binding free energies of inhibitors to plasmepsin II. Journal of Computational Chemistry, 32, 1801–1812.
   PubMedGoogle Scholar
• Suguna, K., Padlan, E. A., Smith, C. W., Carlson, W. D., & Davies, D. R. (1987). Binding of a reduced peptide inhibitor to the aspartic proteinase from rhizopus-chinensis – implications for a mechanism of action. Proceedings of the National Academy of Sciences of the United States of America, 84, 7009–7013.
   PubMed Web of Science ®Google Scholar
• Thangapandian, S., John, S., Sakkiah, S., & Lee, K. W. (2011). Potential virtual lead identification in the discovery of renin inhibitors: Application of ligand and structure-based pharmacophore modeling approaches. European Journal of Medicinal Chemistry, 46, 2469–2476.
   PubMed Web of Science ®Google Scholar
• Tzoupis, H., Leonis, G., Megariotis, G., Supuran, C. T., Mavromoustakos, T., & Papadopoulos, M. G. (2012). Dual inhibitors for aspartic proteases HIV-1 PR and renin: Advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations. Journal of Medicinal Chemistry, 55, 5784–5796.
   PubMed Web of Science ®Google Scholar
• Vieira, E., Binggeli, A., Breu, V., Bur, D., Fischli, W., Guller, R., … Wostl, W. (1999). Substituted piperidines – highly potent renin inhibitors due to induced fit adaptation of the active site. Bioorganic & Medicinal Chemistry Letters, 9, 1397–1402.
   PubMed Web of Science ®Google Scholar
• Wang, J. M., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25, 1157–1174.
   PubMed Web of Science ®Google Scholar
• Wood, J. M., Maibaum, J., Rahuel, J., Grutter, M. G., Cohen, N. C., Rasetti, V., … Bedigian, M. P. (2003). Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochemical and Biophysical Research Communications, 308, 698–705.
   PubMed Web of Science ®Google Scholar
• Xu, Z. R., Cacatian, S., Yuan, J., Simpson, R. D., Jia, L. Q., Zhao, W., … Claremon, D. A. (2010). Optimization of orally bioavailable alkyl amine renin inhibitors. Bioorganic & Medicinal Chemistry Letters, 20, 694–699.
   PubMed Web of Science ®Google Scholar
• Xu, Y. C., Li, M. J., Greenblatt, H., Chen, W. Y., Paz, A., Dym, O., … Sussman, J. L. (2012). Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations. Acta Crystallographica Section D-Biological Crystallography, 68, 13–25.
   PubMed Web of Science ®Google Scholar
• Zhou, A. W., Carrell, R. W., Murphy, M. P., Wei, Z. Q., Yan, Y. H., Stanley, P. L. D., … Read, R. J. (2010). A redox switch in angiotensinogen modulates angiotensin release. Nature, 468, 108–111.
   PubMed Web of Science ®Google Scholar